Omada on GPT obesity drug, halts deal with Boston Scientific, works with Microsoft health executives

Press/Media

Period	27 May 2023

Media coverage

Title	Omada on GPT obesity drug, halts deal with Boston Scientific, works with Microsoft health executives
Media name/outlet	ExBulletin
Country/Territory	United States
Date	27/05/23
URL	ct.moreover.com/?a=50892759689&p=1gw&v=1&x=hT3yAWQuIzctoOqE23uzkw
Persons	Emma Benn